Arterial stiffness is an independent predictor of cardiovascular morbidity and mortality. Brain natriuretic peptide (BNP) and high-sensitivity C-reactive protein (hs-CRP) are considered as novel biomarkers that are useful in the prediction of early cardiovascular risk. We studied the relationship between carotid artery stiffness index b and the cardiovascular biomarkers BNP and hs-CRP in 55 consecutive subjects. Carotid artery stiffness was assessed using the stiffness index b derived from brachial artery blood pressure measurement and carotid ultrasonography. Venous blood samples were obtained for BNP and hs-CRP. Pearson's correlation coefficient suggested a strong bivariate relationship between carotid stiffness index b and age (r ¼ 0.56, Po0.0001), BNP (r ¼ 0.45, Po0.004) and hs-CRP (r ¼ 0.26, P ¼ 0.06), respectively. On multiple regression analysis, significant correlations were found between carotid stiffness index b and age (P ¼ 0.004), BNP (P ¼ 0.027) and hs-CRP (P ¼ 0.029). These findings suggest that there is a relationship between intra-cardiac pressures (measured by BNP), vascular inflammation (measured by hs-CRP) and vascular stiffness. Cardiovascular biomarkers are thus associated with functional parameters of the vascular tree.
Introduction
In large-calibre arteries, there exists a temporal delay between the onset of early, potentially reversible endothelial dysfunction, the subsequent development of structural abnormalities and eventual clinical manifestations of overt atherosclerosis. 1 Thus, detection of preclinical vascular dysfunction could offer a window of opportunity for implementing strategies that could lead to the prevention of clinically significant overt vascular disease.
Arterial stiffness is a marker of endothelial dysfunction that precedes overt atherosclerosis. 2 Arterial stiffness has been consistently proven to be a predictor of adverse cardiovascular outcomes. 3 Stiffness index b is a measure of carotid arterial stiffness that is associated with coronary atherosclerosis 4, 5 and vascular dysfunction 6 in patients with glucose intolerance and insulin resistance.
Vascular inflammation plays a key role in the development of atherosclerotic vascular disease by causing functional changes that precede structural changes in the vascular bed. 7 High-sensitivity C-reactive protein (hs-CRP) is a biomarker that has been used to study vascular inflammation and is a predictor of cardiovascular outcomes. 8 Brain natriuretic peptide (BNP) is another important cardiovascular biomarker that is secreted from cardiomyocytes in response to wall stretch and has diagnostic utility in heart failure. BNP is associated with all-cause mortality and cardiovascular outcomes. 9 There is only limited information available in the literature regarding the association of cardiovascular biomarkers and arterial stiffness. This has been mainly focused on arterial pulse wave velocity and the inflammatory marker hs-CRP. Nearly no information is available regarding BNP and arterial stiffness. The objective of this study was to examine the relationship between carotid artery stiffness, hs-CRP, BNP and conventional risk factors for cardiovascular disease.
Methods

Study subjects
The study protocol was approved by the local institutional review board. We studied 55 consecutive haemodynamically stable subjects with chest pain and negative troponins admitted to a cardiology observation unit in a tertiary care hospital. Patients with acute coronary syndrome, decompensated heart failure, unstable arrhythmias, need for admission to an intensive care unit and patients with end-stage renal disease were excluded from the study.
Carotid artery stiffness measurements All subjects underwent an ultrasound examination of the carotid artery. Patients were examined in the supine position, with the head turned to 451 from the side being scanned and the operator on the right side of the patient. The right common carotid artery was examined just proximal to its bifurcation. The artery was first visualized using B-mode, and subsequently the systolic and diastolic diameters of the artery were measured using M-mode with simultaneous electrocardiographic gating. Three consecutive measurements were obtained for each patient and the average was recorded as the final reading. Carotid distensibility was measured using B-mode-guided M-mode ultrasonography using a 7 Hz transducer (Acuson Sequoia C512, Siemens, Mountain View, CA, USA).
Carotid artery stiffness was measured for each subject using the formula: Stiffness index b ¼ (ln (Ps/Pd)) Â (Dd/(DsÀDd)), where Ps and Pd represent systolic and diastolic blood pressures (BP), respectively; Ds and Dd represent systolic and diastolic diameters, respectively; and ln refers to natural log. 10 All measurements were carried out by a single operator blinded from all the other study parameters.
Blood pressure was measured simultaneously over the brachial artery by sphygmomanometry with the subjects at rest in the supine position.
Blood analysis
On the day of the examination, a venous blood sample was taken for the analysis of hs-CRP (Roche, Basel, Switzerland) and BNP (Triage, Biosite, San Diego, CA, USA).
Statistical analysis
Pearson's correlation coefficient was computed to check for bivariate relationship between carotid stiffness index b and other continuous variables considered in our initial saturated model, and to check for collinearity among the covariates. Multivariable regression analysis was carried out with stiffness index b as the dependent variable and age, race, smoking status, sex, body mass index (BMI), weight, height, systolic BP, diastolic BP, BNP, hs-CRP, high-density lipoprotein cholesterol and triglycerides as the explanatory variables. Stepwise forward and backward method was used for model selection. Normal probability Q-Q-plots were examined for checking data normality. Residuals against predicted values and each of the covariates were plotted for model validation. Cook's distance was measured to check for influential points in our model analysis.
Results
The 55 subjects had a mean age of 51 ± 11 years at enrolment; 51% were male. The mean systolic BP was 125.9 ± 19 mm Hg and mean diastolic BP 76.9 ± 14.4 mm Hg. Sixty-nine per cent were hypertensive, 20% diabetic and 38% had known coronary artery disease. Fifty-three per cent of the study population was black and 40% white. The mean BMI was 33±9.7 kg m -2 . The median for hs-CRP and BNP was 0.31 mg per 100 ml and 15 pg ml -1 , respectively.
Pearson's correlation coefficients suggested a strong bivariate relationship between carotid stiffness index b and age (r ¼ 0.56, Po0.0001), BNP (r ¼ 0.45, Po0.004) and hs-CRP (r ¼ 0.26, P ¼ 0.06), respectively. Figures 1, 2 and 3 show the correlation plots of these bivariate relationships.
Our initial saturated model, the full model, included age, race, smoking status, sex, BMI, weight, height, systolic BP, diastolic BP, BNP, hs-CRP, high-density lipoprotein cholesterol and triglycerides. Stepwise forward and backward model selection method was used. BMI was the only other variable along with age, BNP and hs-CRP that met the 0.15 significance level for entry into the model. The final model retained only three statistically significant variables: age (P ¼ 0.004), BNP (P ¼ 0.027) and hs-CRP (P ¼ 0.029). Table 1 summarizes the results of the final regression model.
Multivariable regression analysis suggested that given age and BNP, hs-CRP significantly correlated with arterial stiffness (P ¼ 0.029): 1 mg per 100 ml increase in hs-CRP led to an increase in arterial stiffness by 2.7 units. Similarly, given age and hs-CRP, BNP significantly correlated with arterial stiffness (P ¼ 0.027): one unit increase in BNP resulted in an increase of 0.034 units in arterial stiffness.
We checked normal probability Q-Q-plots on all our continuous variables that were included in the full model, the initial saturated model. We subsequently made an effort of checking Cook's distance after fitting our model. Cook's distance measures the effect of deleting a given observation. Data points with large residuals (outliers) and/or high leverage may distort the outcome and accuracy of a regression. Points with a Cook's distance of one or more are considered to merit closer examination in the analysis. There were no data points with an estimated influence measured by Cook's distance that exceeded 0.6. Thus, we did not delete any observations from the final data analysis.
To examine the possible confounding effect of BMI, we computed Pearson's correlation coefficients for BMI and hs-CRP (r ¼ 0.21, P ¼ 0.14), BMI and BNP (r ¼ À0.25, P ¼ 0.13), and for BMI and stiffness index b (r ¼ À0.01, P ¼ 0.95). All the P-values are 40.05, suggesting no significant bivariate relationship between BMI and hs-CRP, BNP and stiffness index b, respectively. To further check the confounding effect of BMI on our model, we compared two models: (1) stiffness index b ¼ age þ BNP þ hs-CRP þ BMI and (2) stiffness index b ¼ age þ BNP þ hs-CRP. The estimate coefficient for hs-CRP changed from 2.22 in model (1) to 2.73 in model (2), which was not a significant change suggesting no confounding effect.
On comparing the stiffness index b between blacks (n ¼ 28) and whites (n ¼ 22), we found no difference (P ¼ 0.315). Also, no difference was noted in carotid artery stiffness index b between males and females. In addition, no correlation was noted between hs-CRP and BNP levels.
Discussion
The principal finding of this study is that there is a significant correlation between carotid arterial stiffness (estimated by stiffness index b) and the cardiovascular biomarkers BNP and hs-CRP. In addition, except for age, no correlation was noted between other traditional cardiovascular risk factors and carotid artery stiffness index b.
Arterial stiffness is strongly associated with clinical manifestations of vascular disease affecting largecalibre arteries and is an independent predictor of adverse cardiovascular outcomes. 3, 11 Similarly, carotid artery stiffness has also been shown to have a strong association with vascular disease. 4, 5 In patients with known atherosclerosis, there is an association between increased carotid stiffness and all-cause mortality, 12 cardiovascular events 13 and earlier ischaemic stroke or transient ischaemic attacks. 14 Furthermore, arterial stiffness has now been shown to be an independent predictor of cardiovascular mortality in healthy individuals without known vascular disease. 15, 16 Thus, arterial stiffness is not only a measure of clinically overt vascular disease but also a marker of preclinical vascular dysfunction.
High-sensitivity CRP (hs-CRP) is a marker of systemic inflammation and an independent predictor of long-term cardiovascular outcomes. 8 Systemic inflammation precedes the development of structural vascular disease 7 and is closely associated with increased arterial stiffness. 17 The association between carotid artery stiffness and hs-CRP levels in our study lends further credibility to a putative contribution of vascular inflammation, as measured by hs-CRP levels, towards arterial stiffness. This observation is supported by a similar association seen in studies using aortic pulse wave velocity and radial arterial compliance. [18] [19] [20] It is interesting that, the correlation coefficient between arterial stiffness and hs-CRP in all the above studies as well as in this study is similar (0.27oro0.31).
As most studies showing the association between inflammation and arterial stiffness are cross-sectional in nature, a definitive causal relationship cannot be established. Inflammation causes endothelial dysfunction, which could regulate arterial stiffness through endothelium-derived nitric oxide. 21 Also, inflammation could lead to structural and functional alterations in the extracellular matrix mediated by enzymes such as matrix metalloproteinases of the arterial wall. 22 Irrespective of the underlying mechanism, this finding emphasizes the importance of inflammation (as measured by hs-CRP) and arterial stiffness as closely associated markers of early vascular risk. The recently published JUPITER trial lends credence to the inflammatory hypothesis of vascular dysfunction by showing that statinmediated lowering in CRP levels leads to a significant reduction in major cardiovascular events in healthy subjects without hyperlipidemia. 23 B-type natriuretic peptide is an independent marker of cardiovascular outcomes as well as allcause mortality after adjustment for traditional risk. 9 This association is true even in a range of BNP values that is conventionally regarded as being normal. The implication of these findings is that BNP levels may be elevated before clinically apparent cardiovascular disease, thus serving as a marker of preclinical vascular disease. Our study showed a correlation between BNP levels and carotid artery stiffness b, further supporting this hypothesis. A similar correlation has been shown by others using aortic stiffness (measured by pulse wave velocity) in healthy men and in patients with coronary artery disease. 24 It may be noted that in our study the correlation coefficient between carotid artery stiffness b and BNP (r ¼ 0.46) was much higher than noted in the study by Yambe et al. (r ¼ 0.12). 25 Multiple pathophysiological explanations may be hypothesized for the association between BNP and arterial stiffness. 26 Both BNP and arterial stiffness have been shown to increase with age. Not surprisingly, also in this study, a strong association was noted between carotid stiffness and age. However, controlling for age and hs-CRP, there was still a significant association between BNP and arterial stiffness. Increased cardiac afterload caused by higher arterial stiffness could be an explanation. Arterial stiffness has also been shown to be a marker of diastolic dysfunction in hypertensive patients. 27 Diastolic dysfunction in association with arterial stiffness could explain higher BNP levels in these patients. Indeed, there has been an increasing evidence in recent literature for a role of ventricular-vascular stiffening or coupling that is felt to contribute towards the increasing incidence of heart failure with preserved left ventricular ejection fraction, and consequently leading to a rise in BNP. 28 The limitations of the study should be noted. The cross-sectional nature of the study makes it impossible to infer causal relationships between the associations. High-sensitivity CRP is associated with traditional cardiovascular risk factors, including hypertension, obesity and diabetes, likely because of modulation of the inflammatory response. 29 These cardiovascular risk factors are in turn associated with atherosclerosis and arterial stiffness. In this study, we attempted to obviate any confounding associations between arterial stiffness and cardiovascular biomarkers through multivariable regression analysis. However, significant associations between other variables and biomarkers might exist that could not be detected in this study because of the small sample size. Prospective studies involving larger numbers of patients would need to be carried out to further study the strength of these associations, as well as to explore the underlying pathophysiological basis.
In conclusion, there exists a significant association between carotid arterial stiffness and the cardiovascular biomarkers BNP and hs-CRP. These cardiovascular biomarkers are known to serve as surrogates of preclinical vascular dysfunction. Thus, What is known about this topic K In large arteries there is a temporal delay between the onset of early, reversible vascular dysfunction and eventual clinical manifestations of atherosclerosis. K Arterial stiffness is an independent predictor of cardiovascular morbidity and mortality. K BNP and hs-CRP are cardiovascular biomarkers that are predictors of early cardiovascular risk.
What this study adds K This study suggests a relationship between intra-cardiac pressures (measured by BNP), vascular inflammation (measured by hs-CRP) and carotid artery stiffness. K This finding emphasizes the association between functional abnormalities of large-sized arteries and biological processes represented by the cardiovascular biomarkers. K On the basis of the study further hypotheses can be generated for exploring the mechanisms underlying the relationship between ventricular-vascular coupling and novel cardiovascular markers.
Abbreviations: BNP, brain natriuretic peptide; hs-CRP, high sensitivity C-reactive protein.
our data lend support to the postulation that carotid arterial stiffness could help identify early or preclinical vascular dysfunction in the arterial wall and in turn, help predict future cardiovascular events. Further studies are warranted to explore the mechanisms underlying the relationship between ventricular-vascular coupling and novel cardiovascular markers.
